Literature DB >> 12953170

Secretory Zn2+-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated.

M Górska1, E Barańczuk, A Dobrzyń.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12953170     DOI： 10.1055/s-2003-41810

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  27 in total

Review 1.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

2.  Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity.

Authors:  Jue Wang; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

Review 3.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

4.  Sphingomyelin encrypts tissue factor: ATP-induced activation of A-SMase leads to tissue factor decryption and microvesicle shedding.

Authors:  Jue Wang; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood Adv       Date:  2017-05-23

5.  Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis.

Authors:  Russell W Jenkins; Christopher J Clarke; John Thomas Lucas; Munira Shabbir; Bill X Wu; Fabio Simbari; Joan Mueller; Yusuf A Hannun; John Lazarchick; Keisuke Shirai
Journal:  Am J Hematol       Date:  2013-08-30       Impact factor: 10.047

Review 6.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

Review 7.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

Review 8.  Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids.

Authors:  Delphine Milhas; Christopher J Clarke; Yusuf A Hannun
Journal:  FEBS Lett       Date:  2009-10-24       Impact factor: 4.124

Review 9.  The underlying chemistry of electronegative LDL's atherogenicity.

Authors:  Liang-Yin Ke; Nicole Stancel; Henry Bair; Chu-Huang Chen
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

10.  ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.

Authors:  Anne Hiukka; Marcus Ståhlman; Camilla Pettersson; Malin Levin; Martin Adiels; Susanne Teneberg; Eeva S Leinonen; Lillemor Mattsson Hultén; Olov Wiklund; Matej Oresic; Sven-Olof Olofsson; Marja-Riitta Taskinen; Kim Ekroos; Jan Borén
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.